US 8476442
Process for making modulators of cystic fibrosis transmembrane conductance regulator
granted A61PA61P1/00A61P1/10
Quick answer
US patent 8476442 (Process for making modulators of cystic fibrosis transmembrane conductance regulator) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jul 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P1/00, A61P1/10, A61P1/16, A61P1/18